Beer and Cider Associated with Higher Risk of Gout in Both Sexes vs Other Alcohol Types
Higher alcohol intake was associated with a greater risk of gout for both sexes, but the correlation was stronger in men than women, according to a recent study.
After a False Positive Result, Screening Mammography May Not be a Priority for Some Women
The group of women least likely to return for a regular preventive screening mammogram after a false positive result surprised this primary investigator.
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.
Effectiveness of Suicide Care Implementation in Primary Care: Daily Dose
Your daily dose of the clinical news you may have missed.
Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date
The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.
Researcher Explains How Women Respond to a False Positive Breast Cancer Screening Result
After a false positive outcome on screening mammography, a short interval call back for repeat imaging was a significant deterrent to future screening.
RSV Mortality Higher than for Influenza B After Hospital Discharge: Daily Dose
Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data
CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.
Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.
Early Identification, Treatment of COPD Reduces Exacerbations, Health Care Burden
CHEST 2024. Initial treatment for people with COPD should begin early in the disease and leads to significantly reduced risk for exacerbations and inpatient treatment.
Decrease in MHT Use over Past 2 Decades: Daily Dose
Obesity Management Demands Much More than Medication
Obesity is a complex disease that requires a multispecialty approach to address the physical and also the mental and emotional components of the widespread disorder.
The Potential Harms of Breast Cancer Screening Need to be Explored and this Biostatistician is All In
The most common harm associated with breast cancer screening is a false positive finding; this UC Davis expert wanted to know more about how women respond.
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
Prior SARS-CoV-2 infection was associated with a 2-fold increased risk for MACE for up to 3 years, even among people with no history of CVD, in a new analysis of UK Biobank data.
Ensifentrine, Novel PDE3, PDE4 Inhibitor, Improves Lung Function, QoL Regardless of COPD Severity
The combined bronchodilator/anti-inflammatory agent significantly improved lung function, symptoms and QoL in adults with moderate or severe airflow obstruction.
Preconception Prediabetes in Young Women and Adverse Birth Outcomes: Daily Dose
FDA Black-Box Warnings on Antidepressants Linked to Reduced Treatment, Increased Risk of Suicide Among Youth
The FDA warnings were intended to increase physician monitoring for suicidal thoughts and behaviors but have had dramatic unintended consequences.
FDA Grants Marketing Authorization to First OTC Flu/COVID-19 Test Outside Emergency Use Declaration
The non-prescription test has more than 95% sensitivity and specificity for SARS-COV-2 and influenza A and B and delivers results in approximately 15 minutes.
FDA Approves First-Ever Biologic Medicine for COPD: Daily Dose
Menopausal VMS Education in Primary Care: Build Trust First, Says One Clinician
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.
